David Dilillo

Title: Innovations by David Dilillo

Introduction

David Dilillo is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical research, particularly in the development of innovative therapies. With a total of 3 patents to his name, Dilillo's work has the potential to impact cancer treatment and immunology.

Latest Patents

Dilillo's latest patents include groundbreaking inventions such as the "Anti-New York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1) Antigen-Binding Proteins and Methods of Use Thereof" and "Antigen-Binding Molecules That Bind CD38 and/or CD28, and Uses Thereof." These patents reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

David Dilillo is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate and contribute to the field of biotechnology. His work at Regeneron has positioned him as a key player in the development of new therapeutic approaches.

Collaborations

Dilillo collaborates with talented professionals in his field, including Jessica Kirshner and Aynur Hermann. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

David Dilillo's contributions to medical research and his innovative patents demonstrate his dedication to improving healthcare. His work at Regeneron Pharmaceuticals, Inc. and collaborations with other professionals highlight the importance of teamwork in driving advancements in science.